|

Screening and Care for Fear of Cancer Recurrence in Patients With Cancer at Institut Curie

RECRUITINGSponsored by Institut Curie
Actively Recruiting
SponsorInstitut Curie
Started2025-09-08
Est. completion2026-01-31
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

The goals of this study is to establish the prevalence of severe forms of FCR in the oncology hospital setting, which will require a specific psychotherapeutic response. Two cancer sites are targeted: breast and pulmonary cancers. Secondary objectives include: 1) Determining threshold scores for the FCRI's 9-item severity scale for each type of cancer; 3) To identify a simple item from the FCRI for early detection of FCR in everyday clinical practice, especially using a digital format.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Aged 18 or over
* Clinical or pathological diagnosis of primary or recurrence of a localized/loco-regional or metastatic breast cancer, or a stage 1 or 2, or stage 3 or 4 lung cancer; or a breast or lung cancer metastatic progression
* Three months after completing treatment or three months after the start of a first treatment line for metastatic progression
* Able to comply with the scheduled assessment and interviews
* Able to read and understand the questionnaires' language (i.e. French)

Exclusion Criteria:

* Participating in another patient-reported outcome study interfering with the present study
* Any social, medical or psychological condition hindering questionnaire completion
* Being deprived of personal liberty or under guardianship

Conditions3

Breast CancerCancerLung Cancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.